logo
AAT Bioquest

Transient receptor potential cation channel subfamily M member 2 Inhibitors (IC50, Ki)

Structure
Compound Name
Standard Type
Standard Values (in nM)
N-(p-Amylcinnamoyl)anthranilic acidIC50320.0 [1], 1700.0 [2], 4500.0 [3]
Adenosine monophosphateIC5070000.0 [1]
2-Aminoethyl diphenylborinateIC501000.0 [1]
ClotrimazoleIC503000.0 [1]
Mefenamic acidIC50124000.0 [1]
Flufenamic acidIC5070000.0 [1]
Niflumic acidIC50149000.0 [1]
EconazoleIC503000.0 [1]
3,4-Dihydro-5-(4-(1-piperidinyl)butoxy)-1(2H)-isoquinolinoneIC50600.0 [1]
Salicyl-AMSIC50100000.0 [1]
N-(3-Methylphenyl)anthranilic acidIC5076000.0 [1]
4-[(3S,4R)-1-(2,4-Dichlorophenyl)sulfonyl-4-hydroxy-4-(hydroxymethyl)pyrrolidin-3-yl]oxy-2-fluorobenzonitrileIC5010000.0 [1]
6-Bromo-8-methyl-2-(5-phenyl-1H-pyrazol-4-yl)-2,3-dihydro-1H-quinazolin-4-oneIC504600.0 [1]
6-Chloro-8-methyl-2-(5-phenyl-1H-pyrazol-4-yl)-2,3-dihydro-1H-quinazolin-4-oneIC505100.0 [1]
6-Chloro-8-methyl-2-(5-naphthalen-1-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-quinazolin-4-oneIC504000.0 [1]
6-Bromo-8-methyl-2-(5-naphthalen-1-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-quinazolin-4-oneIC503700.0 [1]
2-(Dimethylamino)-N-(6-oxo-5H-phenanthridin-2-yl)acetamide;hydrate;hydrochlorideIC5025.0 [1]
[[(2R,3S,4R,5R)-5-(6-Amino-8-bromopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC50300000.0 [1]
[[(2R,3S,4R,5R)-5-(6-Amino-8-phenylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] cyclopentyl hydrogen phosphateIC5015000.0 [1]
[4-(6-Aminopurin-9-yl)butoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC50100000.0 [1]
[[(2R,3S,4R,5R)-5-(6-Amino-8-phenylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC5011000.0 [1]
2-Amino-3-[4-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonooxymethyl)oxolan-2-yl]purin-8-yl]phenyl]propanoic acidIC50100000.0 [1]
[[(2R,3S,5R)-5-(6-Amino-8-phenylpurin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC503000.0 [1]
[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] cyclopentyl hydrogen phosphateIC50900000.0 [1]
[[(2R,3S,4R,5R)-5-(6-Amino-8-thiophen-3-ylpurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC5051000.0 [1]
[[(2R,3S,4R,5R)-5-[8-(3-Acetylphenyl)-6-aminopurin-9-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphateIC5049000.0 [1]



References

This online tool may be cited as follows

MLA

"Quest Database™ Transient receptor potential cation channel subfamily M member 2 Inhibitors (IC50, Ki)." AAT Bioquest, Inc.21 Dec2024https://www.aatbio.com/data-sets/transient-receptor-potential-cation-channel-subfamily-m-member-2-inhibitors-ic50-ki.

APA

AAT Bioquest, Inc. (2024December 21). Quest Database™ Transient receptor potential cation channel subfamily M member 2 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/transient-receptor-potential-cation-channel-subfamily-m-member-2-inhibitors-ic50-ki.
BibTeXEndNoteRefMan